Widely available drug may be key in helping sickest Covid-19 patients, study suggests
The widely available steroid drug dexamethasone may be key in helping to treat the sickest Covid-19 patients in the hospital who require ventilation or oxygen, according to researchers in the United Kingdom. Their findings are preliminary, still being compiled, and have not been published in a peer-reviewed journal — but one outside expert called this a “breakthrough.”
The two lead investigators of the Recovery Trial, a large UK-based trial investigating potential Covid-19 treatments, announced to reporters in a virtual press conference on Tuesday that a low-dose regimen of dexamethasone for 10 days was found to reduce the risk of death by a third among hospitalized patients requiring ventilation in the trial.
“That’s a highly statistically significant result,” Martin Landray, deputy chief investigator of the trial and a professor at the University of Oxford, said on Tuesday.
“This is a completely …continued .
[Original Source: CNN]